St. Jude Children's Research Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, St. Jude Children's Research Hospital sits in the top decile of US sponsors by registered trial count (#87 of 15,742 sponsors by registered trial count).
St. Jude Children's Research Hospital: 410 sponsored US clinical trials, 90 recruiting.
St. Jude Children's Research Hospital sponsors 410 registered US clinical trials on ClinicalTrials.gov, 90 of them currently recruiting, and 227 completed. 19 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sickle Cell Disease, with 17 trials.
Top-decile sponsor footprint
St. Jude Children's Research Hospital ranks in the top decile of sponsors by registered trial count (#87 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
227 of 259 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
410 total, page 6 of 9
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
NCT01700959
A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer
NCT01778127
Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
NCT01737554
Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
NCT01644773
St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)
NCT01591213
Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation
NCT01701492
Body Image in Youth With HIV
NCT01673750
Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting
NCT01673243
Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy
NCT01674101
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
NCT01625351
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
NCT01621477
Massive Iron Deposit Assessment
NCT01572922
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
NCT01451515
The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease
NCT01591187
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma
NCT01576692
Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant
NCT01540175
Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program
NCT01569971
Characterization of the Patient Population With Galactosialidosis
NCT01416467
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
NCT01506453
Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients
NCT01473862
Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
NCT01472965
Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma
NCT01498783
The Feasibility Of a Daily Diary Methodology With a Pediatric Cancer Population
NCT01477255
Constraint-Induced Movement Therapy in a Pediatric Oncology Population
NCT01447810
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma
NCT01440283
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
NCT01383473
PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma
NCT01393912
Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen
NCT01328496
Evaluating Therapeutic Boundaries Among Bedside Nurses At A Pediatric Hematology/Oncology Research Hospital
NCT01355731
Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors
NCT01217996
Genes Influencing Iron Overload State
NCT01158794
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
NCT01188798
Epidemiology Of Respiratory Virus Infections In Children
NCT01167361
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
NCT01205581
State Of The Art Functional Imaging In Sickle Cell Disease
NCT01137721
St. Jude Cancer Education for Children Program: Evaluation at 4th-Grade Level
NCT01185093
Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool
NCT01152268
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
NCT01123863
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
NCT01117389
Vibration Intervention For Bone Enhancement In Childhood Cancer Survivors
NCT01010230
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
NCT01068301
Assessment of Sleep Complaints in Brain Tumor Survivors
NCT01102998
Investigating the Needs of Childhood Cancer Survivors: The Unreported Experience
NCT01073735
Evaluation of Cardiovascular Health Outcomes Among Survivors
NCT01003574
Human Immune Responses Toward HIV-1 Envelope Antigens
NCT01344941
Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy
NCT01071473
Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors
NCT01014195
A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique
NCT01042613
Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic Leukemia
NCT00902213
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
NCT00995137
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 87 |
| Phase 2 | 86 |
| Phase 3 | 17 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the St. Jude Children's Research Hospital pipeline
90 recruiting of 410 indexed (22% open); 227 completed (55%).
Phase mix: 19 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Sickle Cell Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
St. Jude Children's Research Hospital: open-pipeline peers nationwide
Peers matched on 410 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
St. Jude Children's Research Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 410 trials (± recruiting share)
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Rutgers, The State University of New Jersey · 413 trials · 26% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Northwell Health · 22% recruiting · 370 trials
- Vanda Pharmaceuticals · 22% recruiting · 68 trials
- Boston University Charles River Campus · 22% recruiting · 104 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
Related
What to do with this St. Jude Children's Research Hospital page
410 registered trials is a research-attention snapshot, not an endorsement of St. Jude Children's Research Hospital or any single study.
- 90 of St. Jude Children's Research Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sickle Cell Disease is the condition St. Jude Children's Research Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sickle Cell Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
St. Jude Children's Research Hospital pipeline card: 410 registered trials from official public datasets.Report a data error.